Subject: TRTC and CNAB Start the Week Strong

SCV Client Spotlight
TRTC and CNAB Start the Week Strong
Hot Stock to WatchHot Stock to Watch

Company: Terra Tech Corp (OTCQB: TRTC)


Price: 0.3495

Change (%): + 0.0695 (24.82)

Volume: 2,304,452

Terra Tech Begins Supercritical CO2 Cannabinoid Extraction, Testing and Formulation

Oakland, Oct. 2, 2014 (GLOBE NEWSWIRE) - Terra Tech Corp (TRTC) is pleased to announce they have begun extracting, testing and formulating compounds at their cannabinoid extraction facility in Northern California. In March of this year the company announced they are developing a research and industrial extraction facility focused on the medical cannabis market. The facility was built in response to what the company views as an increase in demand for high grade CBD as well as other cannabis extracts. At the core of the facility is a custom, 20 liter, 5,000 PSI supercritical CO2 extractor from Eden Labs. This piece of equipment utilizes CO2 as a solvent, which is superior because it is non-flammable and non-toxic, mitigating negative environmental impacts as well as several safety concerns that have been associated with butane extraction.

On September 9, 2014 the company’s Board of Directors unanimously voted to allow the company to engage in the production, extraction and retail sale of medical cannabis if done so in full accordance with the state’s medical marijuana laws in which they operate. The decision was made in advance of Nevada’s November 5th medical marijuana permit announcements. This allows the company’s executive team to transparently operate in the medical cannabis market.

Continue Reading

Company: United Cannabis Corp. (OTCQB: CNAB)


Price: 0.46

Change (%): + 0.04 (9.52)

Volume: 30,282

United Cannabis Corporation Announces Venture With Jamaica-Based Cannabinoid Research & Development Company Limited

DENVER, CO-(Marketwired - Oct 2, 2014) - United Cannabis Corporation (OTCQB: CNAB) (the “Company” or “United Cannabis”) today announced that it has participated with a small group of Jamaicans to form a Jamaican corporation named Cannabinoid Research & Development Company Limited (“CRD” or the “Venture”). The Company owns a fifty percent interest in CRD. The Company participated in the formation of CRD in order to further the Company’s mission of advancing the use of cannabis in medical therapies through biomedical and pharmaceutical research and development, within Jamaica. The Venture has identified a 30,000 square foot facility in Kingston’s industrial zone to serve as its corporate headquarters, but a lease has not yet been signed.

Despite its association with Jamaica and its culture, marijuana has actually been illegal there since the 1961 United Nations Single Convention on Narcotic Drugs. Ironically, the Jamaican government has been hesitant to decriminalize marijuana until now for fear of triggering hinted-at sanctions from Washington. That pressure has diminished in conjunction with the trend toward legalization in the US, and today the Jamaican government announced legislation has been drafted to decriminalize marijuana for medical purposes by the end of 2014.

Continue Reading

Like Us on FacebookFollow Us on Twitter

SmallCapVoice (SCV) is an electronic publication. Information sources for our profiles include, but are not limited to, online research, member suggestions, magazines, newspapers, analyst suggestions, information provided by the profiled company, press releases and similar sources. This communication is not an offer to sell or a recommendation that you buy or sell any security. SCV holds no securities licenses and is not qualified to provide investment advice. We are compensated for these advertisements by the profiled companies. You should not use this newsletter as the sole basis for any investment decision. While all investments involve risk, microcap stocks are among the most risky. Many microcap companies have no proven track record. You should only invest in microcap companies if you can afford to lose your entire investment. You should consult a qualified, licensed financial advisor or stock broker before making any decisions to invest in the securities of any company that is described in these profiles. These profiles are paid advertisements. Although we have a reasonable belief that the information in each profile is accurate, we cannot guarantee that the information is accurate. It is important for you to verify all information by your own independent research. You are receiving this message because you have agreed to receive emails from You may opt out of our distribution list at any time by clicking on the “unsubscribe” link below. Link to full disclosure about compensation paid to, Inc. by companies featured on our website or in our e-mail communications.

About Penny Stocks